Clinical Trial Update: A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy [Phase 4]

View source ↗

Summary

Phase IV pharmacovigilance study update evaluating the safety of Keppra as adjunctive therapy in epilepsy (S.K.A.T.E.) conducted in Greece.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 4 | Status: COMPLETED